1 May 2025 - The MHRA has today approved a vaccine (Vimkunya) used to prevent disease caused by the chikungunya virus in people 12 years of age and older.

This vaccine has been approved through the International Recognition Procedure (IRP). The IRP allows the MHRA to take into account the expertise and decision-making of trusted regulatory partners for the benefit of UK patients.

Read UK Government press release